Literature DB >> 7744805

Nuclear signaling by endothelin-1. A Ras pathway for activation of the c-fos serum response element.

W H Herman1, M S Simonson.   

Abstract

Endothelin-1 (ET-1) regulates gene expression and growth of vascular cells by triggering signals that link its cognate, G protein-coupled receptor in the plasma membrane to transcriptional activation of immediate early genes in the nucleus. To define the nature of these signals, we asked whether Ras proteins contribute to activation of the c-fos serum response element (SRE) by ET-1 in mesangial cells, a microvascular cell from the renal glomerulus. ET-1 stimulated Ras by increasing Ras GTP loading. Addition of ET-1 or transfection with a plasmid expressing v-Ha-Ras stimulated SRE-dependent transcription. Activation of the c-fos SRE by ET-1 was blocked by a dominant negative Asn-17 c-Ha-Ras mutant. Expression of v-Ha-Ras reversed inhibition of ET-1-stimulated SRE transcriptional activity by Asn-17 c-Ha-Ras. ET-1 also stimulated kinase activity of c-Raf-1, a downstream effector in Ras signaling cascades. Activation of the c-fos SRE by transfection with a plasmid expressing constitutively activated delta Raf-1 was consistent with a role for Ras-Raf-1 in ET-1 signaling. Interestingly, Ras-dependent SRE activation in cells treated with ET-1 was blocked by point mutations in the SRE CArG DNA sequence, which binds the serum response factor, but not by mutations that inhibit binding of ternary complex factors (p62TCF) to the Ets DNA sequence of the SRE. Thus, Ras contributes to a nuclear signaling cascade linking ET-1 receptors to transcriptional activation through the CArG cis-element of the c-fos SRE.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744805     DOI: 10.1074/jbc.270.19.11654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Evidence for calreticulin attenuation of cardiac hypertrophy induced by pressure overload and soluble agonists.

Authors:  Sylvia Papp; Ewa Dziak; Golam Kabir; Peter Backx; Sophie Clement; Michal Opas
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

2.  Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor.

Authors:  S Morin; P Paradis; A Aries; M Nemer
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  Molecular targeted therapy in ovarian cancer: what is on the horizon?

Authors:  Roshni Kalachand; Bryan T Hennessy; Maurie Markman
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

4.  Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.

Authors:  M Foschi; S Chari; M J Dunn; A Sorokin
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Src homology 2-containing phosphotyrosine phosphatase regulates endothelin-1-induced epidermal growth factor receptor transactivation in rat renal tubular cell NRK-52E.

Authors:  Chen Cheng-Hsien; Hsu Yung-Ho; Sue Yuh-Mou; Hou Chun-Cheng; Lee Horng-Mo; Huang Huei-Mei; Chen Tso-Hsiao
Journal:  Pflugers Arch       Date:  2005-10-28       Impact factor: 3.657

6.  Voltage-insensitive Ca2+ channels and Ca2+/calmodulin-dependent protein kinases propagate signals from endothelin-1 receptors to the c-fos promoter.

Authors:  Y Wang; M S Simonson
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells.

Authors:  Sumayah Jamal; Robert J Schneider
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Endothelin-1 role in human eye: a review.

Authors:  Serena Salvatore; Enzo Maria Vingolo
Journal:  J Ophthalmol       Date:  2011-03-03       Impact factor: 1.909

9.  ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant.

Authors:  Kenji Tago; Satoshi Ohta; Masaki Kashiwada; Megumi Funakoshi-Tago; Jitsuhiro Matsugi; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  Heliyon       Date:  2017-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.